Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
NEEDHAM, Mass., Aug. 10, 2023 -- Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer, today reported... -Today at 08:02 am- MarketScreener
Source: marketscreener.com